Rekah Pharmaceutical Industry Ltd.

TLV-REKA
Tel Aviv Stock Exchange
Healthcare Drug Manufacturers - Specialty & Generic
Global Rank
#31696
Country Rank
#399
Market Cap
39.79 M
Price
348.58
Change (%)
0.43%
Volume
2,552

TLV-REKA's Next Dividend

Next Estimated Amount
₪43.39
Next Estimated Pay Date
02/01/2037
Last Amount
₪86.78
Last Pay Date
04/14/2022
Dividend Shot Clock Ex-Date: 04/06/2022
0
Days
0
Hours
0
Minutes
0
Seconds
Ex-dividend date passed

Rekah Pharmaceutical Industry Ltd. Dividend Chart

*Amounts are shown in the stock exchange currency (ILS) for convenience

Rekah Pharmaceutical Industry Ltd.(TLV-REKA) Dividend History

Rekah Pharmaceutical Industry Ltd. (TLV-REKA) currently pays an annual dividend of $0.00 per share, offering a dividend yield of 3.78%. The next dividend payout date has not been announced.
Ex-Dividend Date Amount Adj. Amount Dividend Yield Pay Date Change (%)
2022 ₪86.78 ₪86.78 189%
04/06/2022 ₪86.78 ₪86.78 3.78% 04/14/2022 189%
2007 ₪30 ₪30 -50%
06/11/2007 ₪30 ₪30 2.56% 06/25/2007 -50%
2006 ₪60 ₪60 200%
04/24/2006 ₪60 ₪60 3.75% 05/07/2006 200%
2001 ₪20 ₪20 -50%
12/16/2001 ₪20 ₪20 4.77% 12/27/2001 0%
2000 ₪40 ₪40 100%
12/14/2000 ₪20 ₪20 8.27% 12/28/2000 0%
04/10/2000 ₪20 ₪20 2.99% 04/24/2000 0%
1998 ₪20 ₪20
12/22/1998 ₪20 ₪20 4.55% 01/05/1999
*Amounts are shown in the stock exchange currency (ILS) for convenience
*Historical information is adjusted for stock splits

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.